Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 1804835Generated: October 31, 2026

Ammonia → 1-(1-(4-chloro-3-methoxyphenyl)piperidin-4-yl)-2-(5-methyl-3-(trifluoromethyl)-1H-pyrazol-1-yl)ethanamine

https://huagongshe.com/reaction/1804835

Reaction equation

Participants

RoleNameHCIDCharge
ReactantAmmoniaHCID 222—
ReactantAmmonium HydroxideHCID 14923—
ReactantSodium borohydrideHCID 4311764—
Reactant1-(1-(4-chloro-3-methoxyphenyl)piperidin-4-yl)-2-(5-methyl-3-(trifluoromethyl)-1H-pyrazol-1-yl)ethanoneHCID 68554777—
CatalystTitanium isopropoxideHCID 11026—
Solvent1,2-DichloroethaneHCID 11—
SolventEthanolHCID 702—
SolventDichloromethaneHCID 6344—
Product1-(1-(4-chloro-3-methoxyphenyl)piperidin-4-yl)-2-(5-methyl-3-(trifluoromethyl)-1H-pyrazol-1-yl)ethanamineHCID 6855445451.9%

Reaction Steps

A mixture of 1-(1-(4-chloro-3-methoxyphenyl)piperidin-4-yl)-2-(5-methyl-3-(trifluoromethyl)-1H-pyrazol-1-yl)ethanone (941 mg, 2.263 mmol), ammonia (5.7 mL of a 2.0 M solution in EtOH, 11.31 mmol) and titanium(IV) isopropoxide (1.34 mL, 4.53 mmol) was stirred at RT in a tightly stoppered flask for 16 h. At the conclusion of this period, the mixture was treated with anhydrous 1,2-DCE (2 mL), cooled in an ice bath and then treated with sodium borohydride (128 mg, 3.39 mmol) in portions. After 45 min, the mixture had changed to a thick foamy mixture. As a result, 1,2-DCE (3 mL) was added to facilitate stirring and the reaction was stirred for an additional 2 h. After this time, the mixture was poured into aqueous concentrated NH4OH (5 mL), diluted with CH2Cl2 (115 mL) and stirred vigorously for 30 min before being filtered through Celite. The filtrate was placed in a separatory funnel and the phases separated. The aqueous phase was extracted with CH2Cl2 (3 times). The combined extracts were washed with brine, dried (MgSO4) and concentrated to give the crude product. The crude product was purified by flash chromatography on silica gel using EtOAc and 5% MeOH/CH2Cl2 as eluents to provide 1-(1-(4-chloro-3-methoxyphenyl)piperidin-4-yl)-2-(5-methyl-3-(trifluoromethyl)-1H-pyrazol-1-yl)ethanamine (490 mg, 1.175 mmol, 51.9% yield) as a pale yellow solid. 1H-NMR (400 MHz, CDCl3) δ ppm 7.18 (1 H, d, J=8.79 Hz), 6.50 (1 H, d, J=2.42 Hz), 6.41-6.47 (1 H, m), 6.30 (1 H, s), 4.22 (1 H, dd, J=13.84, 3.52 Hz), 3.91-3.99 (1 H, m), 3.87 (3 H, s), 3.69 (2 H, d, J=8.57 Hz), 3.22-3.28 (1 H, m), 2.65-2.75 (2 H, m), 2.33 (3 H, s), 1.89-1.98 (1 H, m), 1.84 (1 H, d, J=9.67 Hz), 1.53-1.63 (3 H, m).

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS08354432B2
Source datasetuspto-grants-2013_01
ORD IDord-9beb565ed7634ce5958a12874cb94ad7
Source noteuspto-grants-2013_01